#term ID	term description	observed gene count	background gene count	strength	signal	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
WP5115	Network map of SARS-CoV-2 signaling pathway	10	218	0.96	0.88	0.00017	9606.ENSP00000236671,9606.ENSP00000306512,9606.ENSP00000338171,9606.ENSP00000345344,9606.ENSP00000352071,9606.ENSP00000365081,9606.ENSP00000370473,9606.ENSP00000378786,9606.ENSP00000385675,9606.ENSP00000389326	CTSD,CXCL8,SKAP1,CTSL,CD163,APOM,IGFBP3,HLA-DRA,IL6,ACE2
WP3617	Photodynamic therapy-induced NF-kB survival signaling	4	34	1.37	0.52	0.0149	9606.ENSP00000162749,9606.ENSP00000294728,9606.ENSP00000306512,9606.ENSP00000385675	TNFRSF1A,VCAM1,CXCL8,IL6
WP4172	PI3K-Akt signaling pathway	9	336	0.73	0.44	0.0152	9606.ENSP00000222390,9606.ENSP00000261405,9606.ENSP00000297494,9606.ENSP00000314897,9606.ENSP00000327513,9606.ENSP00000364979,9606.ENSP00000379111,9606.ENSP00000385675,9606.ENSP00000495951	HGF,VWF,NOS3,ANGPT2,CSF1,COL4A1,IL4R,IL6,KITLG
WP4891	COVID-19 adverse outcome pathway	3	15	1.6	0.53	0.0152	9606.ENSP00000306512,9606.ENSP00000385675,9606.ENSP00000389326	CXCL8,IL6,ACE2
WP5087	Malignant pleural mesothelioma	10	434	0.66	0.43	0.0152	9606.ENSP00000220772,9606.ENSP00000222390,9606.ENSP00000224784,9606.ENSP00000265071,9606.ENSP00000314897,9606.ENSP00000327513,9606.ENSP00000361850,9606.ENSP00000364979,9606.ENSP00000385675,9606.ENSP00000495951	SFRP1,HGF,ACTA2,CDH6,ANGPT2,CSF1,PLAU,COL4A1,IL6,KITLG
WP2848	Pluripotent stem cell differentiation pathway	4	47	1.23	0.5	0.0160	9606.ENSP00000222390,9606.ENSP00000327513,9606.ENSP00000385675,9606.ENSP00000495951	HGF,CSF1,IL6,KITLG
WP3287	Overview of nanoparticle effects	3	19	1.5	0.52	0.0160	9606.ENSP00000306512,9606.ENSP00000364979,9606.ENSP00000385675	CXCL8,COL4A1,IL6
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	8	301	0.72	0.44	0.0160	9606.ENSP00000222390,9606.ENSP00000261405,9606.ENSP00000297494,9606.ENSP00000314897,9606.ENSP00000327513,9606.ENSP00000364979,9606.ENSP00000379111,9606.ENSP00000495951	HGF,VWF,NOS3,ANGPT2,CSF1,COL4A1,IL4R,KITLG
WP4493	Cells and molecules involved in local acute inflammatory response 	3	17	1.55	0.52	0.0160	9606.ENSP00000294728,9606.ENSP00000306512,9606.ENSP00000385675	VCAM1,CXCL8,IL6
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	3	21	1.45	0.51	0.0178	9606.ENSP00000306512,9606.ENSP00000378786,9606.ENSP00000385675	CXCL8,HLA-DRA,IL6
WP2877	Vitamin D receptor pathway	6	183	0.81	0.42	0.0233	9606.ENSP00000220772,9606.ENSP00000242786,9606.ENSP00000275525,9606.ENSP00000340983,9606.ENSP00000367608,9606.ENSP00000370473	SFRP1,ADGRE5,IGFBP1,LRRC25,CA9,IGFBP3
WP3624	Lung fibrosis	4	63	1.1	0.45	0.0233	9606.ENSP00000222390,9606.ENSP00000306512,9606.ENSP00000361850,9606.ENSP00000385675	HGF,CXCL8,PLAU,IL6
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	4	66	1.08	0.45	0.0233	9606.ENSP00000203629,9606.ENSP00000306512,9606.ENSP00000385675,9606.ENSP00000389326	LAG3,CXCL8,IL6,ACE2
WP5284	Cell interactions of the pancreatic cancer microenvironment	3	25	1.38	0.47	0.0233	9606.ENSP00000203629,9606.ENSP00000327513,9606.ENSP00000378786	LAG3,CSF1,HLA-DRA
WP530	Cytokines and inflammatory response	3	26	1.36	0.47	0.0233	9606.ENSP00000327513,9606.ENSP00000378786,9606.ENSP00000385675	CSF1,HLA-DRA,IL6
WP5322	CKAP4 signaling pathway map	5	114	0.94	0.43	0.0233	9606.ENSP00000009530,9606.ENSP00000162749,9606.ENSP00000361850,9606.ENSP00000370542,9606.ENSP00000385675	CD74,TNFRSF1A,PLAU,SDC1,IL6
WP5095	Overview of proinflammatory and profibrotic mediators	5	126	0.9	0.43	0.0235	9606.ENSP00000006053,9606.ENSP00000306512,9606.ENSP00000327513,9606.ENSP00000375086,9606.ENSP00000385675	CX3CL1,CXCL8,CSF1,CCL25,IL6
WP453	Inflammatory response pathway	3	30	1.3	0.45	0.0257	9606.ENSP00000162749,9606.ENSP00000365435,9606.ENSP00000379111	TNFRSF1A,TNFRSF1B,IL4R
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	3	31	1.28	0.45	0.0267	9606.ENSP00000306512,9606.ENSP00000385675,9606.ENSP00000389326	CXCL8,IL6,ACE2
WP5088	Prostaglandin signaling	3	32	1.27	0.44	0.0276	9606.ENSP00000306512,9606.ENSP00000327513,9606.ENSP00000385675	CXCL8,CSF1,IL6
WP5323	Fatty Acids and Lipoproteins Transport in Hepatocytes	8	380	0.62	0.37	0.0276	9606.ENSP00000259486,9606.ENSP00000295834,9606.ENSP00000333664,9606.ENSP00000341141,9606.ENSP00000352071,9606.ENSP00000365081,9606.ENSP00000405453,9606.ENSP00000485276	ENPP2,FABP1,ACAA1,SIGLEC1,CD163,APOM,MSR1,SCARF2
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	3	36	1.22	0.41	0.0345	9606.ENSP00000275525,9606.ENSP00000314897,9606.ENSP00000370473	IGFBP1,ANGPT2,IGFBP3
WP4329	miRNA role in immune response in sepsis	3	37	1.21	0.41	0.0356	9606.ENSP00000294728,9606.ENSP00000306512,9606.ENSP00000385675	VCAM1,CXCL8,IL6
WP289	Myometrial relaxation and contraction pathways	5	156	0.8	0.36	0.0421	9606.ENSP00000224784,9606.ENSP00000275525,9606.ENSP00000297494,9606.ENSP00000370473,9606.ENSP00000385675	ACTA2,IGFBP1,NOS3,IGFBP3,IL6
WP4146	Macrophage markers	2	9	1.65	0.41	0.0421	9606.ENSP00000009530,9606.ENSP00000352071	CD74,CD163
WP4846	SARS-CoV-2 and COVID-19 pathway	2	10	1.6	0.39	0.0475	9606.ENSP00000345344,9606.ENSP00000389326	CTSL,ACE2
